Y-Intercept (HK)’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $515K | Sell |
48,176
-116,307
| -71% | -$1.3M | 0.01% | 1307 |
|
|
2026
Q1 | $1.82M | Buy |
164,483
+47,122
| +40% | +$728K | 0.03% | 762 |
|
|
2025
Q4 | $2.39M | Buy |
117,361
+68,816
| +142% | +$1.21M | 0.05% | 538 |
|
|
2025
Q3 | $768K | Sell |
48,545
-56,333
| -54% | -$832K | 0.02% | 1097 |
|
|
2025
Q2 | $1.4M | Buy |
+104,878
| New | +$1.42M | 0.03% | 775 |
|
|
2025
Q1 | – | Sell |
-74,255
| Closed | -$1.18M | – | 1429 |
|
|
2024
Q4 | $1.18M | Buy |
74,255
+70,561
| +1,910% | +$3.67M | 0.08% | 362 |
|
|
2024
Q3 | $215K | Sell |
3,694
-34,367
| -90% | -$1.7M | 0.01% | 1135 |
|
|
2024
Q2 | $1.74M | Buy |
+38,061
| New | +$2.05M | 0.1% | 285 |
|
|
2024
Q1 | – | Sell |
-5,205
| Closed | -$207K | – | 1581 |
|
|
2023
Q4 | $207K | Buy |
+5,205
| New | +$163K | 0.02% | 991 |
|
